# FDA recall D-060-2013

> **Ranbaxy Inc.** · Class II · drug recall initiated 2012-08-21.

## Product

Atorvastatin Calcium Tablets, 10 mg, 90-count tablets per bottle, Rx only, Manufactured for: Ranbaxy Pharmaceuticals Inc., Jacksonville, FL 32257 USA; by: Ranbaxy Laboratories Ltd., New Delhi -110 019, India; NDC 63304-827-90

## Reason for recall

Adulterated Presence of Foreign Tablets: A product complaint was received by a pharmacist who discovered an Atorvastatin 20 mg tablet inside a sealed bottle of 90-count Atorvastatin 10 mg.

## Distribution

Nationwide

## Key facts

- **Recall number:** D-060-2013
- **Recalling firm:** Ranbaxy Inc.
- **Classification:** Class II
- **Product type:** drug
- **Status:** Terminated
- **Initiation date:** 2012-08-21
- **Report date:** 2012-11-28
- **Termination date:** 2014-03-06

- **Voluntary/Mandated:** Voluntary: Firm initiated
- **Location:** Princeton, NJ, United States

## Primary source

FDA Enforcement Reports: https://www.accessdata.fda.gov/scripts/ires/index.cfm?Product=D-060-2013

## Citation

> AI Analytics. FDA recall D-060-2013. Retrieved 2026-06-02 from https://api.ai-analytics.org/recall/D-060-2013. Source: US FDA. Licensed CC0.

---

*[Dataset catalog](/datasets/) · [FDA recalls dataset](/datasets/fda-recalls) · CC0 1.0*